NIP
LEGN icon

Nicholas Investment Partners’s Legend Biotech LEGN Stock Holding History

Nicholas Investment Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,976
Closed -$335K – 225
2024
Q1 		$335K Sell
5,976
-20,674
-78% -$1.25M 0.03% 198
2023
Q4 		$1.6M Sell
26,650
-566,360
-96% -$35.9M 0.19% 146
2023
Q3 		$39.8M Sell
593,010
-157
-0% -$10.9K 2.97% 3
2023
Q2 		$40.9M Sell
593,167
-22,166
-4% -$1.45M 2.8% 2
2023
Q1 		$29.7M Buy
615,333
+216,218
+54% +$10.6M 2.26% 5
2022
Q4 		$19.9M Sell
399,115
-371
-0.1% -$18K 1.75% 11
2022
Q3 		$16.3M Buy
+399,486
New +$18.8M 1.51% 14

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Nicholas Investment Partners's LEGN Position: Q2 2024 in Review

Nicholas Investment Partners sold out of Legend Biotech (LEGN) in Q2 2024, closing a stake of 5,976 shares — an estimated $335K sold.

Nicholas Investment Partners first reported a position in LEGN in Q3 2022 and held it in 7 quarters. The position peaked at $40.9M in Q2 2023. 181 funds tracked by Wall St. Rank hold LEGN as of Q2 2024.

  • Nicholas Investment Partners reported no remaining Legend Biotech position as of Q2 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 5,976 Legend Biotech shares in Q2 2024, an estimated $335K.
  • Nicholas Investment Partners first reported a position in Legend Biotech in Q3 2022 and held it in 7 quarters.
  • Nicholas Investment Partners's Legend Biotech position peaked at $40.9M in Q2 2023.
  • 181 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2024.

Based on Nicholas Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.